Glenmark Pharmaceuticals informs about press release

06 Sep 2016 Evaluate

Glenmark Pharmaceuticals has informed about a Press Release dated September 06, 2016 titled ‘Glenmark announces the Discovery and Initiation of IND-enabling studies of a novel Bispecific Monoclonal Antibody targeting EGFR’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2019.55 -27.05 (-1.32%)
24-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1737.50
Dr. Reddys Lab 1266.35
Cipla 1496.35
Zydus Lifesciences 917.45
Lupin 2109.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×